Published March 7, 2012 | Version v1
Journal article Metadata-only

Long-term biochemical results after high-dose-rate intensity modulated brachytherapy with external beam radiotherapy for high risk prostate cancer

Creators

  • 1. Department of Radiation Oncology, Hospital Central de Asturias, C/Julian Claveria s/n, Oviedo 33006 (Asturias) (Spain)
  • 2. Department of Radiation Oncology, Hospital Universitario Central de Asturias, Oviedo (Spain)
  • 3. Department of Radiation Physics, Hospital Universitario Central de Asturias, Oviedo (Spain)

Description

Biochemical control from series in which radical prostatectomy is performed for patients with unfavorable prostate cancer and/or low dose external beam radiation therapy are given remains suboptimal. The treatment regimen of HDR brachytherapy and external beam radiotherapy is a safe and very effective treatment for patients with high risk localized prostate cancer with excellent biochemical control and low toxicity

Availability note (English)

Available from http://dx.doi.org/10.1186/1748-717X-7-31; Available from http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3310720

Additional details

Identifiers

URL
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3310720;
DOI
10.1186/1748-717X-7-31;

Publishing Information

Journal Title
Radiation Oncology (Online)
Journal Volume
7
Journal Page Range
p. 31
ISSN
1748-717X

INIS

Country of Publication
United Kingdom
Country of Input or Organization
International Atomic Energy Agency (IAEA)
INIS RN
47061840
Subject category
S62: RADIOLOGY AND NUCLEAR MEDICINE;
Descriptors DEI
BRACHYTHERAPY; EXTERNAL BEAM RADIATION THERAPY; HAZARDS; NEOPLASMS; PROSTATE
Descriptors DEC
BODY; DISEASES; GLANDS; MALE GENITALS; MEDICINE; NUCLEAR MEDICINE; ORGANS; RADIOLOGY; RADIOTHERAPY; THERAPY

Optional Information

Copyright
Copyright (c)2012 Prada et al
Notes
PMCID: PMC3310720; PUBLISHER-ID: 1748-717X-7-31; PMID: 22397528; OAI: oai:pubmedcentral.nih.gov:3310720; licensee BioMed Central Ltd.